logo
#

Latest news with #CEST

Elden Ring Nightreign server down on July 30: Here's when you can access the RPG sequel after 1.02 update
Elden Ring Nightreign server down on July 30: Here's when you can access the RPG sequel after 1.02 update

Time of India

time2 hours ago

  • Entertainment
  • Time of India

Elden Ring Nightreign server down on July 30: Here's when you can access the RPG sequel after 1.02 update

If you're planning to jump into Elden Ring Nightreign on July 30, you might want to pause. The servers will go down for a short maintenance break to apply the new 1.02 patch. The downtime starts at 1 am PDT (1:30 pm IST) and will last just one hour. During this time, you won't be able to access co-op or online modes, but solo offline play will still work. The patch brings some exciting changes, including a new two-player mode and better item filters. Here's everything you need to know about the downtime and when you can get back in. When will the Elden Ring Nightreign servers be back? The servers will be unavailable from: 1 am PDT / 1:30 pm IST / 10 am CEST / 5 pm JST Expected return: 2 am PDT / 2:30 pm IST This applies to PC, PlayStation, and Xbox. During the downtime, players can explore solo content offline, but online co-op and expeditions will be disabled temporarily. The update should go live shortly after servers return. The #ELDENRING #NIGHTREIGN servers will undergo maintenance on July 30, 2025, to deploy Patch will begin at 01:00 PDT | 10:00 CEST | 17:00 JST and will last for one hour on all you for your patience. What's coming in Elden Ring Nightreign patch 1.02? Patch 1.02 for Elden Ring: Nightreign brings two highly requested features that aim to improve both co-op play and general gameplay comfort. The biggest addition is the Duo Expedition mode, which finally allows two players to team up and take on challenges specifically designed for them. This mode adjusts enemy strength, rune rewards, and Nightlord abilities to make battles fair for just two participants. It's a middle ground between solo runs and full three-player squads. Nightfarers, there was an error in the initial PDT timing shared for this Sovereign Augur will be available from July 30, 2025 at 18:00 accept our sincere apologies for any inconvenience. The update also improves the game's Relic filtering system. Players will now have better control when sorting their inventory, with options to filter by damage type, size, rarity, and special effects. This makes finding the right gear much easier, especially for those who like fine-tuning builds. Overall, patch 1.02 focuses on smoother co-op experiences and quality-of-life upgrades, perfect for both new players and veterans looking to optimise their loadouts.

Russia opens new direct flights to North Korea – DW – 07/27/2025
Russia opens new direct flights to North Korea – DW – 07/27/2025

DW

time2 days ago

  • Business
  • DW

Russia opens new direct flights to North Korea – DW – 07/27/2025

Monthly flights from Moscow to Pyongyang were set to begin on Sunday evening in a further sign of the deepening ties between Russia and North Korea. Meanwhile, Russia's Navy Day parade was canceled on "security grounds." The first direct passenger flight from Moscow to Pyongyang since the mid-1990s was set depart on Sunday evening in another sign of the deepening ties between Russia and North Korea. The eight-hour, 6,500-kilometer (4,040-mile) flight, operated by private Russian carrier Nordwind Airlines, was due to take off from Moscow's Sheremetyevo Airport at 19:00 local time (18:00 CEST). The 440 places on the Boeing 777-200ER aircraft quickly sold out, Russian state media claimed, with tickets costing 44,700 rubles ($563, €479). However, the AFP news agency reported that nine tickets were still available on the airline's official website on Sunday morning. Russia's civil aviation authority Rosaviatsia has granted Nordwind Airlines permission to operate flights between the two capital cities twice a week, although the Russian transport ministry said that flights would operate only once a month to begin with in order to "help build stable demand." A return flight from Pyongyang to Moscow is scheduled for Tuesday, according to Russian state news agency TASS. Previously, the only direct air route between Russia and North Korea has been flights by North Korean carrier Air Koryo from Pyongyang to Vladivostok in Russia's Far East three times a week. A direct train connection between Moscow and Pyongyang was reopened on June 17 this year after being suspended during the COVID-19 pandemic. The 10,000-kilometer (6,200-mile) journey takes eight days. Russia and North Korea have increased diplomatic, economic and military ties in the wake of Moscow's full-scale invasion of Ukraine. Kyiv and its Western allies have accused North Korea of supplying Russia with artillery and ballistic missiles to strike Ukrainian cities, while Pyongyang has deployed more than 10,000 troops to help repulse a Ukrainian incursion into Russia's Kursk region. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Meanwhile, the Russian government said on Sunday that an annual navy parade in St. Petersburg was canceled for unspecified "security reasons." Authorities in the northwestern port city canceled the parade on Friday with Kremlin spokesman Dmitry Peskov saying on Sunday that "security comes first." President Vladimir Putin reintroduced Russia's "Navy Day" in 2017 after an almost four-decade absence. In a video message published on Sunday, he praised the "courage" and "heroism" of Russian marines involved in the war of aggression against Ukraine since February 2022. He said the military's most important aim was to "protect the sovereignty and the national interests of the fatherland" and that the navy plays an "important role" in this. The Russian Defense Ministry said on Sunday that around 100 Ukrainian drones had been intercepted over Russian territory, at least ten of which were close to St. Petersburg, which temporarily closed its airport. Further south, Ukrainian drone and missile attacks have effectively forced Russia's Black Sea fleet to abandon its bases in Crimea and retreat further east. The fleet's flagship, the was sunk by Ukrainian forces on April 14, 2022, becoming the largest Russian warship to be sunk since the Second World War.

Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025
Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025

Business Wire

time5 days ago

  • Business
  • Business Wire

Incyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that the Company will present key data from its oncology portfolio at the upcoming European Society of Medical Oncology (ESMO) Congress 2025, to be held October 17-21 in Berlin. 'We're looking forward to presenting the latest findings across our oncology portfolio at this year's congress, including initial data for our TGFβR2×PD-1-directed bispecific antibody, INCA33890, and our novel, selective and orally bioavailable inhibitor of G12D-mutated KRAS, INCB161734,' said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. 'These data underscore the importance of establishing treatment options for advanced solid tumors and speak to the potential of INCA33890 and INCB161734 as personalized therapies to enhance outcomes for patients with cancer across a range of tumor types.' Details on the abstracts accepted for oral presentation at ESMO include: INCB161734 (KRAS G12D) Preliminary Phase 1 Results Of INCB161734, A Novel Oral KRAS G12D Inhibitor, In Patients With Advanced Or Metastatic Solid Tumors​ (Session Title: Proffered paper session: Developmental therapeutics. [October 19, 8:45 – 10:15 a.m. ET [2:45 – 4:15 p.m. CEST]. Abstract #916O.) INCA33890 (PD-1/TGF β R2) A Phase 1 Study Of INCA33890, A PD-1/Tgfβr2 Bispecific Antibody, For Advanced Solid Tumours​ (Session Title: Mini oral session: Investigational immunotherapy. [October 17, 8:00 – 9:30 a.m. ET [2:00 – 3:30 p.m. CEST]. Abstract #1522.) INCAGN2385 (LAG-3) Retifanlimab (Anti–PD-1 Mab) Alone Or In Combination With Anti-LAG3 ± Anti-TIM3 Mabs In Previously Untreated, Recurrent And/Or Metastatic (R/M) PD-L1+ HNSCC: A Double-Blind Randomised Controlled Phase 2 Trial (Session Title: Mini oral session: Head and neck cancer. [October 19, 10:30 a.m. – 12:00 p.m. ET [4:30 – 6:00 p.m. CEST]. Abstract #1325.) All regular abstracts accepted for presentation at the ESMO Congress 2025 will be published online via the ESMO website on Monday, October 13 at 6:05 p.m. ET (12:05 a.m. CEST). All accepted abstracts will be published online in the ESMO Congress 2025 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology. More information regarding the 2025 ESMO Congress can be found at: About Incyte A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia. For additional information on Incyte, please visit or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube. Incyte Forward-Looking Statements Except for the historical information set forth herein, the matters set forth in this press release, including statements regarding the presentation of data from Incyte's clinical development pipeline, the potential offered by INCA33890 and INCB161734, whether or when any development compounds or combinations will be approved or commercially available for use in humans anywhere in the world outside of the already approved indications in specific regions, and Incyte's goal of improving the lives of patients, contain predictions, estimates and other forward-looking statements. These forward-looking statements are based on Incyte's current expectations and subject to risks and uncertainties that may cause actual results to differ materially, including unanticipated developments in and risks related to: unanticipated delays; further research and development and the results of clinical trials possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical trials; determinations made by the FDA, EMA, and other regulatory authorities; the efficacy or safety of Incyte and its partners' products; the acceptance of Incyte and its partners' products in the marketplace; market competition; sales, marketing, manufacturing and distribution requirements; and other risks detailed from time to time in our reports filed with the U.S. Securities and Exchange Commission, including our annual report on Form 10-K and our quarterly report on Form 10-K for the year ended December 31, 2024. Incyte disclaims any intent or obligation to update these forward-looking statements.

DHT Holdings, Inc. to announce second quarter 2025 results on Wednesday, August 6, 2025
DHT Holdings, Inc. to announce second quarter 2025 results on Wednesday, August 6, 2025

Business Upturn

time6 days ago

  • Business
  • Business Upturn

DHT Holdings, Inc. to announce second quarter 2025 results on Wednesday, August 6, 2025

HAMILTON, BERMUDA, July 23, 2025 – DHT Holdings, Inc. (NYSE: DHT or the 'Company') will release its second quarter 2025 results after market close on Wednesday, August 6, 2025. The Company will host a conference call and webcast, which will include a slide presentation, at 8:00 a.m. EDT/14:00 CEST on Thursday, August 7, 2025, to discuss the results for the quarter. To access the conference call the participants are required to register in advance of the conference using this link: Upon registering, each participant will be provided with participant dial-in numbers and a unique personal PIN. Participants will need to use the conference access information provided in the e-mail received at the point of registering. Participants may also use the Call Me feature instead of dialing the nearest dial-in number. The webcast, which will include a slide presentation, will be available on the following link: and can also be accessed in the Investor Relations section on DHT's website at A recording of the audio and slides presented will be available until August 14, 2025, at 14:00 CEST. The recording can be accessed through the following link: About DHT Holdings, Inc. DHT is an independent crude oil tanker company. Our fleet trades internationally and consists of crude oil tankers in the VLCC segment. We operate through our integrated management companies in Monaco, Norway, Singapore, and India. You may recognize us by our renowned business approach as an experienced organization with focus on first rate operations and customer service; our quality ships; our prudent capital structure that promotes staying power through the business cycles; our fleet employment with a combination of market exposure and fixed income contracts; our disciplined capital allocation strategy through cash dividends, investments in vessels, debt prepayments and share buybacks; and our transparent corporate structure maintaining a high level of integrity and corporate governance. For further information please visit Contact:Laila C. Halvorsen, CFOPhone: +1 441 295 1422 and +47 984 39 935 E-mail: [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store